SCHEDULE 13G//SEC Filing
BioXcel Therapeutics, Inc. SCHEDULE 13G
Accession 0001140361-24-049871
CIK 0001403525other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 8:19 PM ET
Size
11.5 KB
Accession
0001140361-24-049871
Documents
Issuer
Oaktree Capital Group Holdings GP, LLC
CIK 0001403525
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001403525
Filing Metadata
- Form type
- SCHEDULE 13G
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 8:19 PM ET
- Size
- 11.5 KB